- **Ultragenyx Pharmaceutical Inc.** reports inducement grant under Nasdaq Listing Rule 5635(C)(4).
Back to newsBrief-Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)RRARE•2026-08-25Company brief Ultragenyx Pharmaceutical Inc. reports inducement grant under Nasdaq Listing Rule 5635(C)(4). Related NewsANasdaq Trade Halt <ARKR.O> Volatility Trading Pause at 03:59 PMARKR•2026-08-25IIntuit's annual forecast falls short of estimates as it prioritizes customer growthINTU•2026-08-25SSemtech Q2 sales, adjusted EPS beat estimates on strong bookingsSMTC•2026-08-25